News

b

b

Current News in Drug Discovery

RSS Nature Reviews Drug Discovery
  • Bridging boundaries: making drug repurposing the new normal May 6, 2026
    Nature Reviews Drug Discovery, Published online: 06 May 2026; doi:10.1038/d41573-026-00074-wThe potential for drug repurposing to provide faster, cost-effective ways to address unmet medical needs remains to be fully realized. Overcoming systemic challenges and promoting collaboration will be key for drug repurposing to contribute more to new treatments, especially for rare diseases.
    Jake Fairnie
  • Novel opioid provides cleaner pain relief May 6, 2026
    Nature Reviews Drug Discovery, Published online: 06 May 2026; doi:10.1038/d41573-026-00067-9Novel opioid provides cleaner pain relief
    Katie Kingwell
  • Shifts in pharma’s therapeutic area focus May 5, 2026
    Nature Reviews Drug Discovery, Published online: 05 May 2026; doi:10.1038/d41573-026-00069-7Shifts in pharma’s therapeutic area focus
    Katarzyna Smietana
  • The landscape for therapeutic cancer vaccines May 1, 2026
    Nature Reviews Drug Discovery, Published online: 01 May 2026; doi:10.1038/d41573-026-00063-zThe landscape for therapeutic cancer vaccines
    Congzhou Chen
  • First-in-class HIV drug nabs approval May 1, 2026
    Nature Reviews Drug Discovery, Published online: 01 May 2026; doi:10.1038/d41573-026-00076-8First-in-class HIV drug nabs approval
    Asher Mullard
  • Dual-vector gene therapy for hearing loss secures first FDA approval May 1, 2026
    Nature Reviews Drug Discovery, Published online: 01 May 2026; doi:10.1038/d41573-026-00075-9Dual-vector gene therapy for hearing loss secures first FDA approval
    Asher Mullard
  • Remodelling complex macrocycles April 28, 2026
    Nature Reviews Drug Discovery, Published online: 28 April 2026; doi:10.1038/d41573-026-00070-0Remodelling complex macrocycles
    Sarah Crunkhorn
  • AhR inhibition promotes axon regeneration April 28, 2026
    Nature Reviews Drug Discovery, Published online: 28 April 2026; doi:10.1038/d41573-026-00072-yAhR inhibition promotes axon regeneration
    Sarah Crunkhorn

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

 BETHESDA, MD, September 17, 2016 − Vitreon America, Inc. participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia.

Attending on behalf of Vitreon America
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America was established with the goal of commercializing their Botanicopeia database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon AmericaTM was formed with the goal of disseminating their BotanicopeiaTM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com